Your search returned 18 studies:
- Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
Conditions: Lung Diseases - Hypertension, Pulmonary
Location: Nashville, Tennessee
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Hypertension
Location: Nashville, Tennessee
- The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
Conditions: Hypertension
Location: Nashville, Tennessee
- The Autonomic Nervous System and Obesity
Conditions: OBESITY - HYPERTENSION - PURE AUTONOMIC FAILURE - SHY-DRAGER SYNDROME
Location: Nashville, Tennessee
- Treatment of Supine Hypertension in Autonomic Failure
Conditions: Hypertension
Location: Nashville, Tennessee
- Nebivolol in the Supine Hypertension of Autonomic Failure
Conditions: Hypertension - Pure Autonomic Failure - Multiple System Atrophy
Location: Nashville, Tennessee
- The Role of Endothelin in the Supine Hypertension of Autonomic Failure
Conditions: Hypertension - Pure Autonomic Failure - Multiple System Atrophy
Location: Nashville, Tennessee
- Pathophysiology of Cardiometabolic Risk Factors in African Americans
Conditions: Obesity - Hypertension
Location: Nashville, Tennessee
- Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension
Location: Nashville, Tennessee
- Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Conditions: Hypertension - Pure Autonomic Failure - Multiple System Atrophy
Location: Nashville, Tennessee
- Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Conditions: Persistent Pulmonary Hypertension - Respiratory Failure
Location: Nashville, Tennessee
- Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Conditions: Hypertension - Diabetes Type 2
Location: Nashville, Tennessee
- Selexipag (ACT-293987) in Pulmonary Arterial Hypertension, GRIPHON Trial
Conditions: Pulmonary Arterial Hypertension
Location: Nashville, Tennessee
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Hypertension, Pulmonary
Location: Nashville, Tennessee
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled NITROsyl
Conditions: Pulmonary Arterial Hypertension - Idiopathic Pulmonary Fibrosis
Location: Nashville, Tennessee
- Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Conditions: Uncontrolled Hypertension
Location: Nashville, Tennessee
- Adult Congenital Heart Disease Registry (QuERI)
Conditions: Pulmonary Arterial Hypertension - Congenital Heart Disease
Location: Nashville, Tennessee
- Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil i
Conditions: Hypertension
Location: Nashville, Tennessee
|